Table 4 |
|||
|
Average costs of diagnostic tests in the control and intervention groups using 85% of MBS fees ($/per patient). |
|||
| Control n = 185 (95%CI) |
Intervention n = 745 (95%CI) |
Mean cost reduction |
|
|
|
|||
| Clinical costs |
|||
|
|
|||
| D-dimer |
6.30 (5.50–7.10) |
10.90 (10.60–11.10) |
-4.60 |
| VQ |
235.80 (213.50–258.10) |
177.50 (165.40–189.50) |
58.30 |
| LLUS |
29.60 (21.10–38.10) |
25.30 (21.40–29.30) |
4.30 |
| CTPA |
42.40 (23.00–61.80) |
37.10 (28.10–46.20) |
5.30 |
|
|
|||
| Protocol implementation cost |
|||
|
|
|||
| Preparing protocol materials and conducting training sessions |
0 |
1.60 |
-1.60 |
| Attending training sessions |
0 |
2.40 |
-2.40 |
| Total |
314.10 (283.00–345.10) |
246.80 (228.60–265.00) |
59.30 |
|
|
|||
|
Gospodarevskaya et al. Cost Effectiveness and Resource Allocation 2006 4:12 doi:10.1186/1478-7547-4-12 |
|||
